Follow us on:
Breaking News
March 16, 2026
Breaking News
Breaking News
Samsung_Webinar_04-15-26_650x90

Celltrion’s Avtozma Available in Subcutaneous Formulation for US Patients

 
Celltrion’s Avtozma Available in Subcutaneous Formulation for US Patients

The treatment is one of the first tocilizumab biosimilars to be approved by the FDA in both SC and intravenous formulations.
Read More >>

Headlines

Breaking News

Sartorius Launches Eveo Cell Therapy Platform

New integrated system is designed to address structural manufacturing bottlenecks that limit scalability and patient access to transformative treatments.

SPONSOR

Move Beyond Trial and Error with Causal AI

Bring scientific rigor to pharmaceutical manufacturing with causal AI that reduces experiments and enables faster, evidence based, and defensible decisions.

Breaking News

Samsung Bioepis, Epis NexLab Partner with G2GBIO to Develop Novel Semaglutide Assets

Will advance novel assets based on G2GBIO’s proprietary microsphere technology.

Breaking News
Collaborations & Alliances

Aptar Pharma, COVIRIX Medical Partner on Inhaled Antiviral Treatments

If successful, the finished product could potentially be used against numerous pandemic-potential respiratory viruses.

SPONSOR

Bend Bioscience’s Expanded Vision for Complex Drug Delivery

CEO Owen Murray on driving innovation with high science and high service.

Interphex_Enl_031626_650x250

Breaking News
Promotions & Moves

Korsana Biosciences Taps Dr. Mark Vignola as CFO

Vignola brings extensive leadership experience in corporate finance across the biotech industry.

SPONSOR

[VideoBite] Overcoming Solubility Challenges at Hovione’s Expanded NJ Site

David Basile of Hovione discusses expanded spray drying capacity in East Windsor and the benefits of integrated development, scale-up, and manufacturing at a single U.S. site.

Featured Resources

Solution Content Centers SPOTLIGHT

Praxis Packaging Solutions

Contract packaging demands flexibility, efficiency, and control. At Praxis, we deliver all three through the innovative, cost effective application of manual labor and the skillful use of automated and custom packaging equipment. We've been doing so for about a quarter century. Our OTC/Rx pharmaceutical, consumer products, and medical device customers choose us for four reasons: a relentless focus on compliance, astonishing speed-to-market, unyielding accountability, and significant category experience. At Praxis, we don't just deliver innovative, turnkey packaging solutions. We provide them while exceeding our customers' expectations, while managing their critical deadlines, and while upholding rigorous regulatory and quality standards. You could call it agility; we call it Managed Rapid Response, and here at Praxis, it's at the heart of what we do. Upholding standards is so deeply engrained at Praxis that, since the company was formed, we've had exactly zero recalls.

 

Solution Content Centers SPOTLIGHT

Sentry BioPharma Services ApS

Sentry BioPharma Services ApS (Sentry EU) is a contract service organization (CSO) which supports the life science industry throughout the drug development life cycle by offering cGMP temperature-controlled storage, distribution, logistics, and EMA compliant labeling and packaging services. Sentry EU's Qualified Person (QP) facilitates import/export of pharmaceuticals to/from the EU via QP audits, QP-to-QP agreements, and batch certification/declarations. Sentry EU’s validated software, cGMP storage and drug distribution facility, industry expertise, and stringent quality standards support pharmaceutical supply chain integrity throughout manufacturing, packaging, storage and distribution.